A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed

This study will check how well a new medicine, GSK5764227, works, how safe it is and how the body handles it in participants all around the world with advanced inoperable or metastatic gastrointestinal cancer who have previously received treatment.

Trial Details

NCT ID
NCT06885034
Phase
PHASE1 / PHASE2
Sponsor
GlaxoSmithKline
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • GSK5764227
Locations (sample)
  • Los Alamitos, California, United States|33.80307,-118.07256
  • Whittier, California, United States|33.97918,-118.03284
  • New York, New York, United States|40.71427,-74.00597
  • Durham, North Carolina, United States|35.99403,-78.89862
  • Houston, Texas, United States|29.76328,-95.36327

Key Eligibility Criteria

  • Participants are eligible to be included in the study only if all of the following criteria apply:
  • Is at least 18 or the legal age of consent in the jurisdiction in which the study is taking place years of age at the time of signing the informed …
  • CRC Cohort
  • Has histologically confirmed unresectable/, locally advanced or unresectable metastatic adenocarcinoma of the colon or rectum (histology defined by…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →